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Abstract
Background: Nutritional changes during and after tuberculosis treatment have not been well described. We
therefore determined the effect of wasting on rate of mean change in lean tissue and fat mass as measured by
bioelectrical impedance analysis (BIA), and mean change in body mass index (BMI) during and after tuberculosis
treatment.
Methods: In a prospective cohort study of 717 adult patients, BMI and height-normalized indices of lean tissue
(LMI) and fat mass (FMI) as measured by BIA were assessed at baseline, 3, 12, and 24 months.
Results: Men with wasting at baseline regained LMI at a greater rate than FMI (4.55 kg/m2 (95% confidence interval
(CI): 1.26, 7.83 versus 3.16 (95% CI: 0.80, 5.52)) per month, respectively during initial tuberculosis therapy. In contrast,
women with wasting regained FMI at greater rate than LMI (3.55 kg/m2 (95% CI: 0.40, 6.70) versus 2.07 (95% CI: -0.74,
4.88)), respectively. Men with wasting regained BMI at a rate of 6.45 kg/m2 (95% CI: 3.02, 9.87) in the first three
months whereas women, had a rate of 3.30 kg/m2 (95% CI: -0.11, 6.72). There were minimal changes in body
composition after month 3 and during months 12 to 24.
Conclusion: Wasted tuberculosis patients regain weight with treatment but the type of gain differs by gender
and patients may remain underweight after the initial phase of treatment.
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Background
A cardinal feature of tuberculosis patients is marked
wasting at time of disease diagnosis [1-3]. Wasting associ-
ated with tuberculosis is likely caused by a combination of
decreased appetite and altered metabolism resulting from
inflammatory and immune responses [4-6]. Decreased
appetite compounds the increased metabolic demands
of the chronic inflammation associated with tuberculosis.
Although antituberculosis treatment is highly effective [7],
many patients remain underweight after 6 months of
treatment [8] suggesting that full recovery takes longer
than drug treatment itself.
In patients with both tuberculosis and HIV co-infection,
wasting may be exacerbated [6,9]. Findings from some
cross-sectional studies show no large differences in body
composition between HIV sero-positive and sero-negative
adults with tuberculosis at presentation [10-13] although
gender may be a confounding factor [1,12].
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Although several reports have described the nutri-
tional changes at the time of tuberculosis diagnosis using
both anthropometry and bioelectrical impedance analysis
(BIA) [4,10,12,14-16], follow-up studies to explain nutri-
tional changes during and after tuberculosis treatment are
limited. Yet such information would provide the basis for
designing nutritional interventions to rescue the wasting
associated with tuberculosis.
Previous studies [1,17] found weight gain to be a poor
indicator of clinical response in tuberculosis. Moreover,
weight or body mass index (BMI) provides limited infor-
mation about nutritional alterations in a patient. Measure-
ment of body composition is necessary to obtain a better
picture of the nutritional status in tuberculosis because
body compartments differ in their contribution to weight
gain and to clinical benefit. Lean tissue mass and fat mass
as body composition measurements have been shown to
permit a more precise evaluation of nutritional status
[18,19]. Lean tissue mass is more closely correlated with
quality of life, physical functioning and survival than are
fat mass and body weight [20-22]. BIA is a useful non-
invasive and cost-effective method for clinical assessment
of lean tissue and fat mass despite its limitations [23,24].
In this large retrospective study, we have demonstrated
the effect of baseline wasting and HIV infection on rate of
change in lean tissue mass, fat mass, and BMI during and




We conducted a prospective cohort study of 745 adults
(age ≥ 18 years) with initial episode pulmonary tubercu-
losis, defined baseline body wasting and confirmed HIV
status. The data were generated from subjects enrolled
in the Household Contact study [25-27] and in the pla-
cebo arm of a randomized placebo-controlled clinical trial
that used prednisolone as an adjunct treatment among
HIV patients with tuberculosis [28]. Data for the inter-
vention arm of this trial was not used in the present
study because prednisolone has adverse nutritional effects.
The institutional review boards at Case Western Reserve
University in the United States and Joint Clinical Research
Center in Uganda reviewed the protocol and final approval
was obtained from the Uganda National Council for
Science and Technology. All participants provided writ-
ten informed consent for enrollment into the study and
were given appropriate pre- and post-test HIV counseling
and AIDS education.
At enrollment, basic demographic information and med-
ical history were collected by self report, and a standardized
physical examination was conducted by a medical officer.
Active tuberculosis was confirmed by sputum smear mi-
croscopy and culture. Patients with active tuberculosis
were treated with standard four-drug chemotherapy for
tuberculosis in accordance with the Ugandan Ministry of
Health guidelines. HIV-1 infection was diagnosed on the
basis of a positive enzyme-linked immunosorbent assay
for HIV-1 antibodies (Recombigen; Cambridge Biotech,
Cambridge, MA). BMI was available at baseline and
follow-up for all subjects whereas BIA baseline and
follow-up data were available for only a subset of 278
participants from the household contact study.
Nutritional status was assessed using anthropometric
measurements (height and weight) and BIA (RJL Systems,
Quantum II, Detroit, MI). Weight was determined to the
nearest 0.1 kg using a SECA adult balance scale, and
standing height was determined to the nearest centimeter.
Anthropometric and BIA measurements were performed
on the day patients were confirmed to have tuberculosis
disease and at scheduled visits including baseline, 3, 12,
and 24 months on follow-up using the same equipment
and standard conditions [23]. Body-mass index (BMI) was
computed using the relationship of weight in kilograms
divided by height in meters squared (kg/m2).
Single-frequency BIA was performed at 50 kHz and
800 mA with standard tetrapolar lead placement [29]. Be-
fore performing measurements, the BIA instrument was
calibrated using the manufacturer’s recalibration device.
The resistance and reactance were based on measures of a
series circuit [30]. BIA measurements were performed in
triplicate for each subject after resting the participant for a
minimum of 2 hours, having voided their bladder, no alcohol
intake in previous 24 hours and at ambient temperature.
Average measurements were used in the analysis. Lean tissue
mass was calculated from BIA measurements using equa-
tions that were previously cross-validated in a sample of
patients (white, black and Hispanic) with and without HIV
infection [30] and have been applied elsewhere in
African studies [10,15,16]. Fat mass was calculated as
body weight minus lean tissue mass.
We used BMI and height-normalized indices (ad-
justed for height2) of body composition that partition
BMI into lean tissue mass index (LMI) and fat mass
index (FMI) [18,19,31] to establish the body wasting sta-
tus of participants. The LMI and FMI have the advan-
tages of compensating for differences in height and age
[24]. Also, use of LMI and FMI eliminates some of the
differences between population groups. We defined
body wasting as patients having low LMI (<16.7 (kg/m2)
for men and <14.6 (kg/m2) for women) and low FMI
(<1.8 (kg/m2) for men and <3.9 (kg/m2) for women) [19]
corresponding to WHO BMI categories (<18.5 kg/m2) for
malnutrition among adults as previously reported [32].
Statistical analysis
The main aim of the analysis was to examine the change
in body composition during and after tuberculosis
Mupere et al. BMC Infectious Diseases 2014, 14:24 Page 2 of 10
http://www.biomedcentral.com/1471-2334/14/24
treatment as measured by LMI, FMI, and BMI; and to
relate these changes to baseline wasting. Based on our
previous findings [12,22], we hypothesized that rate of
change in LMI, FMI, and BMI would differ in patients
with or without baseline wasting and it would also differ
by sex.
The main outcome vectors of the participant’s LMI,
FMI, and BMI were modeled as linear combinations of
baseline covariates and baseline wasting status in separate
multilevel linear random mixed models with random
intercept and random slope, accounting for correlation of
repeated measurements within each individual [33-35].
We used the full maximum likelihood estimation method
for parameter estimation and type 3 F-test for testing sig-
nificance. We assumed a spatial exponential covariance
structure because the intervals between serial data points
were different by design. Piecewise linear mixed models
[36,37] were used to assess, for a given measure, the
change in gradient over time at the knot for month 3 and
at month 12. The knots in the piecewise were chosen a
priori basing on the scheduled data point measurements.
The main predictor was baseline wasting and the follow-
ing were other covariates used to assess associations with
the dependent variables overtime: HIV sero-status; anemia
(hemoglobin ≤10 mg/dl); prior smoking status; history of
weight loss; and extent of disease on chest x-ray catego-
rized as normal/minimal and moderate/far advanced. The
interval between study visits was adjusted to an annual
scale to facilitate the interpretation of rates of LMI, FMI,
and BMI decline per year.
Data missingness was assumed not to be informative
on outcome variable and ignorable after performing separ-
ate generalizing estimating equations models for LM, FMI,
and BMI using Proc GENMOD with a logit link function
to assess the effect of having wasting versus no wasting
at baseline on to probability of missing overtime [38].
To assess for the confounding effects of HIV and gen-
der, we fitted stratified models according to HIV strata
and gender. The analyses were performed using SAS
MIXED procedures [39] and SAS version 9.1.3 Cary
software, North Carolina SAS Institute Inc. 2004.
Results
Baseline characteristics of the study population
Of the 745 participants who were available, 28 were
excluded due to lack of anthropometric follow-up data,
leaving 717 participants in total for analysis. Of the 717
participants, 628 were from the household contact
study and 89 from the placebo arm of the randomized
controlled trail. The household contact and the placebo
arm of the randomized controlled trial participants had
comparable baseline characteristics including gender
(p = 0.109), wasting as measured by BMI (p = 0.286), and
proportion of anemic individuals (hemoglobin ≤10 mg/dl)
(p = 0.170); however, differences were observed for current
smoking status (p = 0.020), and extent of disease on chest
radiography (p = 0.004). All the 717 participants had serial
BMI measurements and 13% (92/717) of the 717 died on
follow-up. A subset 278 from the household contact study
of the 717 participants had LMI and FMI follow-up data
for analysis. Of the 278 who had BIA data, 8% (22/278)
died on follow-up. The 717 participants and the 278
subset of participants with BIA data had comparable
baseline characteristics including wasting as measured
by BMI (p = 0.45), gender (p = 0.56), proportion of anemic
individuals (hemoglobin ≤10 mg/dl) (p = 0.59), current
smoking status (p = 0.95), and extent of disease on chest
radiography (p = 0.13).
Of the 717 patients who were included in the analysis,
293 (41%) were wasted as defined by BMI <18.5 kg/m2
at baseline (Table 1). Of the 278 participants with BIA
baseline and follow-up data, 94 (34%) were wasted as
measured by LMI. Of the 278 patients, 120 (43%) were
wasted as measured by FMI (Table 1). There were gender
differences in wasting status. Men had significantly greater
reductions in LMI and BMI compared to women whereas
women had significantly greater reductions in FMI com-
pared to men (Table 1). There were no differences in wast-
ing between HIV positive and HIV negative patients by
any of the nutritional assessment measurements.
Impact of wasting and gender on rate of mean change in
LMI during and after treatment
The effect of wasting as measured by LMI was associated
with a significant gain in LMI at a rate of 2.68 (95% CI:
0.68, 4.67) kg/m2 per month during the first three months
of treatment after adjusting for HIV, status of anemia,
prior smoking status, history of weight loss, and extent
of disease on chest x-ray (Figure 1a; Additional file 1:
Table S1 and Additional file 2: Table S2). Patients who
presented with no wasting had gradual increase in LMI
at a rate of 0.36 (95% CI: -1.38, 2.08) kg/m2 per month.
There were gradual changes in LMI after three months
and after treatment regardless of wasting status at baseline
(Figure 1a; Additional file 1: Table S1 and Additional
file 2: Table S2). Patients who presented with wasting did
not regain LMI to the same level as those who presented
without wasting.
When we stratified to test for the confounding effects of
gender and HIV on gain in LMI over time, men had a
higher LMI at presentation than women. Men with wasting
regained LMI at a greater rate of 4.55 (95% CI: 1.26, 7.83)
kg/m2 than women at 2.07 (95% CI: -0.74, 4.88) kg/m2 per
month during the first 3 months of treatment (Figure 1b
and c; Additional file 1: Table S1 and Additional file 2:
Table S2). A similar pattern was seen among patients
without wasting at baseline (Figure 1b and c; Additional
file 1: Table S1 and Additional file 2: Table S2).
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After the first 3 months of treatment, LMI gain was
reduced in both men and women. Both HIV sero-
positive and sero-negative patients regained LMI over
first 3 months and after three months; however, there
was comparable tendency for HIV sero-negative
patients to regain at the same rate as HIV sero-positive
patients (Figure 1d).
Impact of wasting and gender on rate of mean change in
FMI during and after treatment
Patients regained FMI over time, up to 24 months
regardless of baseline fat wasting as measured by low
FMI; however, there was a tendency for patients with
baseline fat wasting to gain FMI at higher rate compared
to those with preserved fat tissue (Figure 2a; Additional
file 1: Table S1 and Additional file 2: Table S2). During
the first three months, patients who presented with
wasting had a significant gain in FMI at rate of 2.23
(95% CI: 0.30, 4.16) kg/m2 per month whereas patients
who presented with normal fat mass had minimal change
at a rate of −0.11 (95% CI: -1.98, 1.73) kg/m2 per month
after adjusting for HIV, prior smoking status, history of
weight loss, and extent of disease on chest x-ray (Figure 2a;
Additional file 1: Table S1 and Additional file 2: Table S2).
There were minimal changes in FMI after month 3 and
before month 12 among women and men regardless of
initial fat mass wasting status.
During the first three months in stratified analysis
(Figure 2b and c; Additional file 1: Table S1 and Additional
file 2: Table S2), women had higher FMI at diagnosis
than men. Among patients who presented with wasting,
women gained more FMI at rate of 3.55 (95% CI: 0.40,
6.70) kg/m2 per month compared to men at rate of 3.16
(95% CI: 0.80, 5.52). Regarding HIV status, there were
minimal changes in FMI regardless of the initial fat
mass level suggesting that both HIV sero-positive and
Table 1 Baseline characteristics of tuberculosis patients with/or without baseline wasting in urban Uganda, Kampala
Characteristic LMI FMI BMI
No wasting Wasting No wasting Wasting No wasting Wasting
(n = 184) (n = 94) (n = 158) (n = 120) (n = 424) (n = 293)
Age (years)
≤30 (%) 122 (66) 54 (57) 99 (63) 77 (64) 252 (59) 170 (58)
>30 (%) 62 (34) 40 (43) 59 (37) 43 (36) 172 (41) 123 (42)
Sex
Female (%) 115 (62) 19 (20)a 65 (41) 69 (58)b 232 (55) 115 (39)a
Male (%) 69 (38) 75 (80) 93 (59) 51 (42) 192 (45) 178 (61)
HIV-serostatus
Negative (%) 105 (57) 53 (56) 90 (57) 68 (57) 198 (47) 140 (48)
Positive (%) 79 (43) 41 (44) 68 (43) 52 (43) 226 (53) 153 (52)
Hemoglobin (mg/dl)1
>10 (%) 140 (76) 72 (77) 135 (85) 77 (64)a 208 (81) 118 (64)a
≤10 (%) 44 (24) 22 (23) 23 (15) 43 (36) 48 (19) 67 (36)
Smoker2
No (%) 159 (87) 56 (60)a 127 (80) 88 (74) 364 (86) 210 (72)a
Yes (%) 24 (13) 38 (40) 31 (20) 31 (26) 58 (14) 82 (28)
Takes alcohol3
No (%) 135 (74) 59 (63) 106 (67) 88 (74) 259 (61) 192 (66)
Yes (%) 48 (26) 35 (37) 52 (33) 31 (26) 164 (39) 101 (34)
Extent on chest x-ray4
Normal/minimal (%) 38 (21) 8 (9)b 26 (17) 20 (17) 74 (18) 33 (11)b
Moderate/far advanced (%) 143 (79) 86 (91) 131 (83) 98 (83) 346 (82) 257 (89)
Weight loss5
No (%) 32 (17) 12 (13) 31 (20) 13 (11) 107 (25) 52 (18)b
Yes (%) 151 (83) 82 (87) 126 (80) 107 (89) 315 (75) 240 (82)
ap-value <0.001, bp-value <0.05; p-values obtained by chi-square test. BMI = body mass index, LMI = Lean tissue mass index, FMI = fat mass index. 1276 missed
hemoglobin measurement due to lack of blood for BMI data; 4three missed extent variable in BIA data and 7 in BMI data; 3one missed history of prior smoking in
BIA data and 3 missed in BMI data; 3one missed history of alcohol intake for BMI and BIA data; 5one missed history of weight loss for BIA data and 3 missed in
BMI data; LMI wasting (<16.7 kg/m2 for men and <14.6 kg/m2 for women, normal (≥ 16.7 kg/m2 for men, ≥14.6 kg/m2 for women); reduced BMI <18.5 kg/m2.
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sero-negative patients regain FMI at similar rates
(Figure 2d).
Impact of wasting and gender on rate of mean change in
BMI during and after treatment
During the first three months, BMI gain was at the rate of
3.83 (95% CI: 1.67, 5.99) kg/m2 per month among patients
who presented with wasting compared to the rate of 2.25
(95% CI: 0.33, 4.17) kg/m2 per month among patients who
presented with no wasting after adjusting for HIV, status
of anemia, prior smoking status, history of weight loss,
and extent of disease on chest x-ray (Figure 3a; Additional
file 1: Table S1). The magnitude in BMI gain among
patients who presented with wasting was higher in men
at rate of 6.45 (95% CI: 3.02, 9.87) and minimal in
women at a rate of 3.30 (95% CI: -0.11, 6.72) (Figure 3b
and c; Additional file 1: Table S1 and Additional file 2:
Table S2). Similar results were obtained among the 89
participants from the placebo arm of the randomized
controlled trail. There were gradual changes in BMI
after month 3 and during the one year of follow-up after
month 12 in the overall population and in stratified
models for women and men (Figure 3b and c;
Additional file 1: Table S1 and Additional file 2: Table S2).
There were minimal differences in BMI gain between HIV
sero-positive and sero-negative patients over the entire
24 months period (Figure 3d).
Discussion
In this prospective cohort study of 717 adults who had
BMI measurements and in the subset of 278 of the 717
who had BIA measurements in urban Uganda, body
wasting was associated with a dramatic linear gain in
BMI and gain in both LMI and FMI in the initial three
months of tuberculosis treatment, respectively. The rate
of increase varied by gender but not by HIV status of the
patient. Men with wasting at baseline regained lean tissue
mass at a greater rate than fat tissue mass during initial
tuberculosis therapy. In contrast, women with wasting
regained fat mass at greater rate than lean tissue mass.
Men without wasting regained lean tissue mass without
substantial gain in fat mass, whereas women without
wasting had minimal changes in lean tissue or fat mass.
There were minimal changes in body composition after
three months of tuberculosis treatment and during the
one year period of follow-up after month 12 among
regardless of the initial body composition, gender and
HIV status. This suggests that patients remain under-
weight after 3 months of treatment. Full nutritional
recovery takes much longer than treatment itself, and
may never fully catch-up in those who at the time of
Figure 1 Panels show mean profiles for LMI among patients with baseline lean tissue wasting versus no wasting (a); among men with
baseline wasting versus no wasting (b); among women with baseline wasting versus no wasting (c); and among HIV positive versus
negative patients (d).
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tuberculosis diagnosis were wasted as previously re-
ported [40]. It is also possible that a substantial proportion
of patients with potential to regain in body composition
might have died because of marked wasting at time of
tuberculosis diagnosis [20-22]. HIV appears to play a mar-
ginal role for changes in body composition in co-infected
individuals.
This study is the first to report that the initial LMI and
BMI influence subsequent changes in body composition
among men with tuberculosis. Results of the present study
are consistent with previous studies [41] that revealed
total lean tissue increased during the first six weeks of
tuberculosis treatment and thereafter the increase was
in the fat mass compartment. In our present study,
there were minimal changes in body composition after
month 3 including slight increase, in fat mass among
men. The prior study [41]; however, was limited in
sample size with only 36 participants because it was a
prospective randomized clinical trial. The study popu-
lation comprised of only patients who were wasted
(BMI <18.5 kg/m2), had no HIV comparison group,
and followed patients for only 6 months. The strengths
of the present study include: large number of study
participants comprising both women and men, wasted
and not wasted persons, HIV positive and HIV negative
individuals, and long duration of follow-up.
The present study demonstrates that patients who
presented with reduced fat and lean tissue mass gained
in body composition at a higher rate than patients who
presented with normal levels of fat and lean tissue mass,
particularly during the first three months of tubercu-
losis treatment. However, the gain was predominantly
fat mass among women whereas men gained predomin-
antly lean tissue mass plus substantial levels of fat mass.
The potential explanation appears to rest on the gender
differences in lean tissue mass content. Women tend to
have low lean tissue mass compared to men, yet lean
tissue mass has been shown to be a significant deter-
minant of fat oxidation [42,43]. In several reports after
adjusting for differences in lean tissue mass, resting fat
oxidation is lower in women than men [42,44,45]. Thus,
this gender differences in fat metabolism as explained
elsewhere [46-48], is associated with lower basal fat oxida-
tion that may contribute to the increased fat storage or
gain in women compared to men. Moreover, longitudinal
studies have shown that low rates of fat utilization predict
subsequent weight [49]. Besides differences in lipolysis,
other factors such as differences in hormone action may
contribute to differences in fat oxidation. Higher levels of
androgens in men stimulate the formation of the nucleic
acids essential for protein biosynthesis [50] with eventual
increase in lean tissue and recent studies [51] postulate
Figure 2 Panels show mean profiles for FMI among patients with baseline fat wasting versus no wasting (a); among men with baseline
wasting versus no wasting (b); among women with baseline wasting versus no wasting (c); and among HIV positive versus negative
patients (d).
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that major sex hormones such estrogen and testosterone
are central to weight management.
In normal healthy adults, protein catabolism equals pro-
tein anabolism; however, protein catabolism exceeds pro-
tein anabolism in tuberculosis [52]. In general; however,
the linear increase in lean tissue during the first three
months among patients who presented with reduced lean
tissue mass levels suggest that patients with tuberculosis
can mount a protein anabolic response during treatment
once bacterial burden is reduced and controlled [5,52]. It
may be possible that as the patient becomes sterile from
the causative organism during treatment, the degree of
body wasting offsets the tuberculosis effect on protein ca-
tabolism until a net state of anabolism [53]. Alternatively,
the response could be explained by the effective adaptive
response of protein metabolism to a chronic inflammatory
state [54].
Despite the dramatic linear increase in lean tissue
mass, fat mass, and BMI among patients who presented
with body wasting, these patients did not normalize their
indices for body composition. Wasted patients did not
regain body composition comparable to patients pre-
senting without wasting. There may be several explana-
tions for this. It is possible that patients who present
with wasting at the time of tuberculosis diagnosis were
of slim body build before disease as compared to the
patients who present with normal nutritional status as
previously reported that patients with slim body build
were at increased risk for tuberculosis [55]. While on
tuberculosis treatment, the patients with body wasting
apparently regain the original body composition status
prior to onset of tuberculosis disease. Following attain-
ment of the original body composition, there are min-
imal changes in lean tissue and individuals adapt
effective energy-sparing mechanism in balance with the
usual energy intake [56,57]. It is also possible that
households where tuberculosis occurs in Uganda, and
in other countries in sub-Saharan region, there is food
insecurity compromising energy intake. Thus, persist-
ently low body composition may mark lack of access to
sufficient calorie, protein, and other nutrient intake. It
is also possible that tuberculosis causes permanent loss
of lean tissue that cannot be regained. The persistently
low body composition measures even after effective tuber-
culosis treatment may be a marker for future health risk.
Among patients with wasting who do not normalize, there
may be consequences regarding survival and physical
function in response to future disease insults. Further
research is needed to understand the health risk among
these patients.
Figure 3 Panels show mean profiles for BMI among patients with baseline body mass wasting versus no wasting (a); among men with
baseline wasting versus no wasting (b); among women with baseline wasting versus no wasting (c); and among HIV positive versus
negative patients (d).
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In this study, we used the BIA method to measure
body composition, yet it is not a reference standard like
dual-energy x-ray absorptiometry. The BIA prediction
method used has not yet been validated in the local
population. As a result, findings of body composition
may be biased because of variations in hydration across
ethnic groups [23]. However, the equations that were
used in this study were previously cross validated in in-
dividuals of different races (white, black, and Hispanic)
among men and women, who were both healthy con-
trols and HIV-infected patients [30]. Moreover, the
equations have been used widely in other studies from
Africa with meaningful findings [10,12,15,16]. Further,
our findings are similar to studies that used state-of-the
art reference methods [58]. We also took care to take
measurements at rest, with proper placement of leads,
in participants who had not exercised or taken alcohol,
in participants with voided bladder and ambient
temperature. However, measurements were in patients
with underlying illness that may cause shifts in body
water compartments, thereby affecting measurements
of fat mass. Our findings are also limited by the lack of
dietary intake assessment to give further insight in the
interpretation of gender differences in longitudinal body
composition changes and we did not evaluate HIV dis-
ease severity.
Conclusions
Despite limitations of the present study, this study sug-
gests that the body regains weight among wasted tubercu-
losis patients. Patients with wasting do not recover to the
same levels of body mass as those who were not wasted.
This suggests that tuberculosis leads to permanent loss of
lean tissue and fat mass. There was remarkable gender but
not HIV differences in longitudinal body composition
changes during the initial phase of tuberculosis treatment
among patients who presented with body wasting. The
substantial body composition differences between men
and women suggest that the nutritional demands during
recovery may differ for men and women. Evaluation of nu-
tritional status should involve evaluation of lean tissue and
fat mass and further studies should explore the impact of
providing nutritional interventions as adjuvant treatment
on body composition among tuberculosis patients during
and after treatment in sub-Saharan Africa.
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